CLChae Young Lee

Chae Young Lee

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Chae Young Lee has a total of 35 co-authors. Here are the top co-authors by number of shared publications:

  • Eun-Jin Kim

    Division of Emerging Infectious Diseases, Department of Laboratory Diagnosis and Analysis, Korea Disease Control and Prevention Agency, Cheongju-si, Republic of Korea

    6 shared publications
  • Il-Hwan Kim

    Division of Vectors and Parasitic Diseases, Korea Disease Control and Prevention Agency, 187 Osongsaengmyeong 2-ro, Osong-eup, Heungdeok-gu, Cheongju 28159, Chungbuk, Republic of Korea

    6 shared publications
  • Ae Kyung Park

    Division of Emerging Infectious Diseases, Bureau of Infectious Diseases Diagnosis Control, Korea Disease Control and Prevention Agency (KDCA), Cheongju, Korea

    4 shared publications
  • Jee Eun Rhee

    Division of Emerging Infectious Diseases, Bureau of Infectious Diseases Diagnosis Control, Korea Disease Control and Prevention Agency (KDCA), Cheongju, Korea

    4 shared publications
  • Jeong-Min Kim

    Korea Disease Control and Prevention Agency

    4 shared publications
  • Jin Sun No

    Division of Emerging Infectious Diseases, Department of Laboratory Diagnosis and Analysis, Korea Disease Control and Prevention Agency, Cheongju 28159, Republic of Korea

    4 shared publications

Latest Publications

  • Open Access

    Long-Term Genomic Surveillance and Immune Escape of SARS-CoV-2 in the Republic of Korea, with a Focus on JN.1-Derived Variants

    by Il-Hwan Kim, Eun Ju Lee, Jin Sun No, Ji Yeong Noh, Chae Young Lee, Sang Won O, Yong Jun Choi, Jeong-Ah Kim, Bo Min An, Jeong-Hyun Nam, et al.

    Since the onset of the COVID-19 pandemic, the Republic of Korea has experienced continuous waves of SARS-CoV-2 variants. The current study aimed to analyze the long-term trends of variant prevalence and associated changes in immune responses within the country. Whole-genome sequencing was performed on confirmed patient samples collected from December 2020 to May 2025, and variant distribution, genetic diversity, and neutralization were compared. As a result of analyzing a total of 157,962 gene sequences, various Omicron sub-lineages, including BA.1, BA.2, BA.5, followed by JN.1, KP.3, and NB.1.8.1, were seen to circulate sequentially over time. The nucleotide diversity of the SARS-CoV-2 genome gradually increased after the JN.1 outbreak. Of the tested variants, hamster antiserum neutralization analysis indicated that Omicron NB.1.8.1, which began to circulate in 2025, exhibited the lowest neutralization activity, with an approximately 6.6-fold decrease compared to JN.1. This suggests a potential expansion in the dominance of new variants with enhanced immune evasion. As the transmission of SARS-CoV-2 continues, new variants with novel characteristics may emerge; therefore, continuous national genomic surveillance and immunological characterization are considered crucial for early detection of emerging variants and for guiding effective public health responses.


  • Open Access

    Neutralization Testing–based Immunogenicity Analysis of Recent Prevalent Severe Acute Respiratory Syndrome Coronavirus 2 Omicron Sublineages

    by Eun Ju Lee, Hyeokjin Lee, Sang Won O, Jee Eun Rhee, Jeong-Min Kim, Dong Ju Kim, Il-Hwan Kim, Jin Sun No, Ae Kyung Park, Chae Young Lee, et al.

    Eun Ju Lee, M.S., Hyeokjin Lee, M.S., Sang Won O, M.S., Jee Eun Rhee, Ph.D., Jeong-Min Kim, Ph.D., Dong Ju Kim, M.S., Il-Hwan Kim, Ph.D., Jin Sun No, Ph.D., Ae Kyung Park, Ph.D., Jeong-Ah Kim, Ph.D., Chae Young Lee, B.S., Young-Ki Choi, Ph.D., and Eun-Jin Kim, Ph.D.. Ann Lab Med 2024;44:289-93. https://doi.org/10.3343/alm.2023.0256

  • Three distinct ORF1a recombinants of the SARS-CoV-2 Delta variant of concern

    by Dong-Wook Lee, Jeong-Min Kim, Da-Won Kim, Ji-Yun Kim, Chae Young Lee, Jin Sun No, Il-Hwan Kim, Jee Eun Rhee, Eun-Jin Kim, Jung-Hoon Kwon

  • Open Access

    Increased viral load in patients infected with severe acute respiratory syndrome coronavirus 2 Omicron variant in the Republic of Korea

    by Jeong-Min Kim, Dongju Kim, Nam-Joo Lee, Sang Hee Woo, Jaehee Lee, Hyeokjin Lee, Ae Kyung Park, Chae Young Lee, Il-Hwan Kim, Cheon Kwon Yoo, et al.

    Objectives: Coronavirus disease 2019 (COVID-19) has been declared a global pandemic owing to the rapid spread of the causative agent, severe acute respiratory syndrome coronavirus 2. Its Delta and Omicron variants are more transmissible and pathogenic than other variants. Some debates have emerged on the mechanism of variants of concern. In the COVID-19 wave that began in December 2021, the Omicron variant, first reported in South Africa, became identifiable in most cases globally. The aim of this study was to provide data to inform effective responses to the transmission of the Omicron variant.Methods: The Delta variant and the spike protein D614G mutant were compared with the Omicron variant. Viral loads from 5 days after symptom onset were compared using epidemiological data collected at the time of diagnosis.Results: The Omicron variant exhibited a higher viral load than other variants, resulting in greater transmissibility within 5 days of symptom onset.Conclusion: Future research should focus on vaccine efficacy against the Omicron variant and compare trends in disease severity associated with its high viral load.


  • Open Access

    Rapid Emergence of the Omicron Variant of Severe Acute Respiratory Syndrome Coronavirus 2 in Korea

    by Ae Kyung Park, Il-Hwan Kim, Chae Young Lee, Jeong-Ah Kim, Hyeokjin Lee, Heui Man Kim, Nam-Joo Lee, SangHee Woo, Jaehee Lee, JeeEun Rhee, et al.

    Ae Kyung Park, Ph.D., Il-Hwan Kim, Ph.D., Chae Young Lee, B.S., Jeong-Ah Kim, Ph.D., Hyeokjin Lee, M.S., Heui Man Kim, Ph.D., Nam-Joo Lee, M.S., SangHee Woo, M.S., Jaehee Lee, B.S., JeeEun Rhee, Ph.D., Cheon-Kwon Yoo, Ph.D., and Eun-Jin Kim, Ph.D.. Ann Lab Med 2023;43:211-3. https://doi.org/10.3343/alm.2023.43.2.211


  • Open Access

    Genomic Surveillance of SARS-CoV-2: Distribution of Clades in the Republic of Korea in 2020

    by Ae Kyung Park, Ae Kyung Park, Il-Hwan Kim, Il-Hwan Kim, Junyoung Kim, Junyoung Kim, Jeong-Min Kim, Jeong-Min Kim, Heui Man Kim, Heui Man Kim, et al.

    Since a novel beta-coronavirus, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) was first reported in December 2019, there has been a rapid global spread of the virus. Genomic surveillance was conducted on samples isolated from infected individuals to monitor the spread of genetic variants of SARS-CoV-2 in Korea. The Korea Disease Control and Prevention Agency performed whole genome sequencing of SARS-CoV-2 in Korea for 1 year (January 2020 to January 2021). A total of 2,488 SARS-CoV-2 cases were sequenced (including 648 cases from abroad). Initially, the prevalent clades of SARS-CoV-2 were the S and V clades, however, by March 2020, GH clade was the most dominant. Only international travelers were identified as having G or GR clades, and since the first variant 501Y.V1 was identified (from a traveler from the United Kingdom on December 22nd, 2020), a total of 27 variants of 501Y.V1, 501Y.V2, and 484K.V2 have been classified (as of January 25th, 2021). The results in this study indicated that quarantining of travelers entering Korea successfully prevented dissemination of the SARS-CoV-2 variants in Korea.